improving adherence in adults with hypertension using
TRANSCRIPT
University of LouisvilleThinkIR: The University of Louisville's Institutional Repository
Doctor of Nursing Practice Papers School of Nursing
8-2019
Improving Adherence in Adults with Hypertensionusing Personalized Pictogram Pill CardsJanneve P. Sankawulo-KnucklesUniversity of Louisville, [email protected]
Follow this and additional works at: https://ir.library.louisville.edu/dnpPart of the Nursing Commons
This Doctoral Paper is brought to you for free and open access by the School of Nursing at ThinkIR: The University of Louisville's InstitutionalRepository. It has been accepted for inclusion in Doctor of Nursing Practice Papers by an authorized administrator of ThinkIR: The University ofLouisville's Institutional Repository. This title appears here courtesy of the author, who has retained all other copyrights. For more information, pleasecontact [email protected].
Recommended CitationSankawulo-Knuckles, Janneve P., "Improving Adherence in Adults with Hypertension using Personalized Pictogram Pill Cards"(2019). Doctor of Nursing Practice Papers. Paper 37.Retrieved from https://ir.library.louisville.edu/dnp/37
Running head: IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION USING
PERSONALIZED PICTOGRAM PILL CARDS
by
Janneve P. Sankawulo-Knuckles
Paper submitted in partial fulfillment of the
requirements for the degree of
Doctor of Nursing Practice
University of Louisville
School of Nursing
Date Finalized
Signature DNP Project Chair
&(h~Signature DNP Project Committee Member
~ekfA~
Si~~~;~
Date
Date
Date
Signature Associate Dean for Academic Affairs Date
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 2
Acknowledgments
I would like to begin by thanking God for the wisdom, knowledge, and strength he gave
me to impart on, and complete this great journey. This experience has truly straightened my faith
and I know now that I can handle whatever comes my way. I would also like to thank everyone
for their support for me and my family as we traveled down this road to success. Next, I would
like to thank Park DuValle Community Health Center and Donald E. Morisky for their support in
conducting this project.
To my family, I say thank you for believing in me. To my husband, Miller Knuckles, I
say thank you for sacrificing your desires, so that I may carry out my dream, and for being my
breath and heartbeat when I felt like giving up. To my children, Brian, Christian, and Tristian, I
say thank you for being my hope and my motivation for excellence. I am extremely proud to be
your mother and want to lead you to greatness and leave behind a tradition of success. To my
parents, Stanley and Rose Cooper, I say this is for all your hard work and sacrifices you've made
in support of my destiny. To my younger siblings, Stanton, Stanlia, Tokonjay, Iyadeh, Leela, and
Stanleymae, I say thank you for believing in me and encouraging me every step of the way.
Much thanks to my committee chair Dr. Mary DeLetter for her countless hours of
reflecting, reading, encouraging, and most of all her patience throughout the entire process.
Thanks for reminding me to “stay the course.” To my committee member, Dr. Sara Robertson, I
say thanks for your encouragement and guidance throughout this process. You all were more
than generous with sharing your expertise and precious time.
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 3
Dedication
I dedicate my work to my family and friends. A special feeling of gratitude to my loving
grandparents, Wilton and Amelia Sankawulo whose words of encouragement and push for
tenacity ring in my ears. Though you both have passed on, you have never left my side and are
very special. I will always appreciate what you’ve done for me. Although you are no longer with
us in the physical––you remain my greatest cheerleaders.
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 4
Table of Contents
Manuscript Title Page ............................................................................................................1
Acknowledgments..................................................................................................................2
Dedication ..............................................................................................................................3
Manuscript Abstract ...............................................................................................................6
Manuscript .............................................................................................................................7
Table 1: Pre- and Post-MGL Medication Adherence Scale Results .......................................17
Table 2: Pre- and Post-MGL Medication Adherence Scale Identified Risk Findings ...........17
References ..............................................................................................................................21
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 5
Improving Adherence in Adults with Hypertension Using Personalized Pictogram Pill Cards
Janneve P. Sankawulo-Knuckles
The University of Louisville, School of Nursing
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 6
Abstract
Non-adherence with prescribed hypertension (HTN) treatment significantly increases the risk for
cardiovascular disease and stroke, leading to increased morbidity, mortality, and burden to the
health care system. HTN affects one in three American adults and costs the health care system
approximately $48.6 billion annually in direct (providers/health professionals fees, hospital
services, prescription medications) and indirect (premature mortality) medical expenses (CDC,
2018; 2016). This quality improvement (QI) project implemented a personalized pictogram pill
card intervention for adults with HTN at an urban, federally-qualified health care clinic in west
Louisville. Pictogram pill cards were provided to hypertensive adults with medium and low
adherence score on the Morisky, Green, and Levine (MGL) Medication Adherence Scale (1986).
Medication count at Day 1 was compared to Day 30 count to determine the percentage of
adherence. In a sample of 10 patients, nine showed improved medication adherence following
the pill card intervention. Mean adherence score was 99.16 ± 2.37. This evidence-based
intervention using pictograms in medication instructions was a valuable tool to improve
adherence to antihypertensive medications in patients with HTN.
Keywords: Hypertension; medication adherence, non-adherence, pictograms, pill card
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 7
Improving Adherence in Adults with Hypertension Using Personalized Pictogram Pill Cards
Hypertension (HTN) is one of the most critical risk factors for the development of
cardiovascular disease (CVD) and stroke (Centers for Disease Control and Prevention [CDC],
2018; HealthyPeople.gov, 2019). HTN affects approximately one in three American adults, or
about 75 million people in the US (CDC, 2018). Although there are adequate medical therapies
for HTN management, only about 48.3% of persons with HTN have their blood pressure (BP)
controlled (Chang, Ritchey, Ayala, Durthaler, & Loustalot, 2018; Fryar, Ostchega, Hales, Zhang,
& Kruszon-Moran, 2017).
One factor contributing to this low percentage of blood pressure control is patient non-
adherence to prescribed regimens. Non-adherence is defined as the degree to which people’s
behaviors agree with medication regimens from health care providers (Leporini, De Sarro, &
Russo, 2014). Non-adherence rates range from 20-50% and include not filling prescriptions and
not taking medications as prescribed (American College of Preventative Medicine, 2011; Fryar
et al., 2017; & US Department of Health and Human Services [DHHS], 2016). As a result, there
are approximately 1,000 HTN-related deaths daily in the U.S. (CDC, 2014).
Many factors influence patients’ adherence to prescribed regimens, including
complexity and side effects of regimen, quality of life, health care system issues, behavioral,
demographic, lack of knowledge regarding HTN, and treatment and clinical variables. The risk
of CVD and stroke from HTN has surpassed diabetes mellitus (DM), obesity, and smoking,
accounting for 49% of CVD and 62% of stroke (American Heart Association, 2013). Between
the years 2015 and 2016, the prevalence of HTN among American adults was 29.0% and
increased with age: age group 18–39, 7.5%; 40–59, 33.2%; and 60 and over, 63.1% (Fryar et al.,
2017). Projections show that by 2030, approximately 41.4% of American adults will have HTN,
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 8
an increase of 12.4% (Fryar et al., 2017). Uncontrolled HTN is associated with increased
morbidity and mortality and increased use of health care resources (Yoon et al., 2015).
According to the CDC, annual direct (providers/health professionals fees, hospital services,
prescription medications) and indirect (premature mortality) medical expenses for persons with
HTN are approximately $48.6 billion (CDC, 2016). Promoting medication adherence is a major
clinical hurdle that is necessary to decrease CVD and stroke morbidity and mortality (Hamilton,
2003; Wogen & French, 2004).
Clinical Questions
The following clinical question guides this project: How will the implementation of an
educational pictogram pill card intervention improve antihypertensive medication adherence in
adult patients with a diagnosis of HTN when compared to usual medication education?
Summary of the Literature
Literature shows pictogram use in medication instruction as favorable for improving
adherence. Yet, there is a lack of pictogram use in practice. Pictograms add benefits to
medication instruction and should be considered as a means of improving adherence. Several
studies have been conducted to illustrate the effectiveness of pictogram use in medication
instruction.
In a 2006 study by Mansoor and Dowse’s pictograms used in the medication education of
Native South African patients taking co-trimoxazole tablets significantly aided comprehension
and adherence. A comprehension rate of 92% was determined in experimental group B (those
receiving a simple patient information leaflet incorporating pictograms) as compared to 78% in
experimental group A (those receiving a complex patient information leaflet) and 70.0% in the
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 9
control group (those receiving no patient information leaflet). The difference between the
experimental group B and the other two groups was statistically significant (p < 0.05).
A similar study by Braich, Almeida, Hollands, and Coleman (2011) assessed the
effectiveness of pictograms on adherence to postoperative cataract eye drops in low literacy
patients. They found that experimental group 2, taught with both pictograms in the clinic and for
utilization at home, showed higher amounts of medication consumption (p < 0.001). Taking
pictograms home was the most effective way to educate causing an increase in the adherence rate
to regimens by 28 days or more.
In 2003 Mansoor and Dowse compared the comprehension of labels and patient
information sheets containing text-only with those containing text and pictograms. Sixty
participants were assigned to either the control group (looking at material containing only text)
or the experimental group (looking at material containing text and pictograms) and asked to read
a nystatin suspension label and answer six questions. Comprehension of the label was rated
according to the number of questions answered correctly. All but two participants in the
experimental group achieved 100% understanding of the label incorporating pictograms.
However, less than half (40%) of the control group understood the label. This difference was
significant (p = 0.001) (Mansoor & Dowse, 2003).
Dowse and Ehlers (2005) saw similar results in a more extensive study (N=87) that
assessed comprehension and adherence using text-only (control) or text-plus-pictogram
(experimental) labels for prescribed antibiotics in a mostly female (93%), low-literacy
population. Participants were allocated to two groups: a control group that received text-only
labels and an experimental group that received text and pictogram labels. Participants we
examined 3-5 days after initiation of therapy to evaluate adherence. Recall and understanding of
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 10
the medicine instructions were assessed using a series of questions and a cumulative score of
understanding was calculated based on questions answered correctly. Adherence was determined
by self-reporting and by “pill count”. A rating out of 10 was converted into a percentage. Dowse
and Ehlers (2005) found that in 54% of the experimental groups, an adherence of greater than
90% was achieved, compared with only 2% in the control group. Average understanding of the
medicine instructions in the control and experimental groups were 70% and 95%, and average
adherence was 72% and 90%.
Advani et al. (2013) investigated the use of pictograms and written medication
instructions over six weeks in patients filling or refilling prescriptions at a chosen pharmacy.
Two sets of handouts with patient information were designed, one with pictogram-based patient
information and the other with textual substance. A patient-administered survey assessed four
criteria of the handout received: user-friendliness, long-term comprehension, the likelihood of
the participants referencing the handout in the future, and the effectiveness of the pill card. Based
on a five-point Likert scale, the survey assessed the perception of four measurable variables to
best gauge the effect on patient attention, understanding, memory, and adherence. Advani et al.
(2013) evaluated patient perceptions of the actual impact of pictogram-based handouts on
attention, understanding, remembering, and adherence. They found that the addition of
pictograms increased the likelihood of the patient referencing the handout for understanding.
Wilby et al. (2011) concluded that the use of pictograms on medication vials as a means
of improving patients' understanding of HIV medication information had a positive influence on
understanding and adherence compared to text alone. Eighty-two adults were randomized to
either a control group (n=42) receiving standard counseling or an experimental group (n=40)
receiving pictogram-enhanced medication information for 18 months. Pictogram stickers was
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 11
placed on the medication vial representing the targeted information for that medication and
verbal explanation provided of the meaning of the pictogram as it related to that drug. Each vial
contained the standard label, usually dispensed by the ambulatory pharmacy. Patients in the
intervention group were shown drugs with pictogram stickers, and those in the control group
were shown drugs without pictogram stickers. For each medication, pharmacists asked the
patient, "What can you tell me about this medication?" and documenting their response. Patients
who reported the targeted information were scored as giving the correct answer, and those who
did not were scored as providing an incorrect response. The intervention group correctly
identified the majority (88%) of the targeted pieces of information at follow-up, compared to
only 2% in the control group. Concluding that pictograms improve the recall of targeted
medication information among patients receiving antiretroviral therapy for HIV management.
Kripalani et al. (2007) evaluated the development and implementation of a pill card using
pictograms (pill images and icons) that depicts a patient’s daily medication regimen. They found
a large percentage (83%) of participants used the pill card when they initially received it and also
three months later. Majority of the pill card users (92%) rated this adherence tool as very easy on
understandability. Most of the participants (94%) found the pill card helpful in remembering
important medication information, such as the name, purpose, and time of administration. Nearly
all patients considered the pill card to be a useful and readily understood tool to assist with
medication management.
A similar pictorial aid intervention (PictureRx) as in the study by Kripalani et al. (2007)
was pilot-tested by Monroe et al. (2018) to evaluate its effect on medication adherence in both
patients with HIV and other common chronic conditions. Forty-six adult patients with HIV and
DM or HTN from an underserved clinic were enrolled in this study. Patients were randomly
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 12
selected to receive either a photographic representation of their medication’s instructions (n=23)
or standard (n=23) discharge medications instructions. The intervention group received
pictogram representations of the appearance, indication, and daily dosing schedule for each of
their medications. The PictureRx card was provided to the patient, along with their regular
discharge medication list. Among all 46 participants, there was a trend towards higher adherence
to medications for HIV compared with drugs for HTN/DM (baseline median medication
possession ratio (p = 0.07) for antiretroviral therapy and comorbid condition was 0.92 and 0.79,
respectively).
Pictograms use in medication instruction has shown positive results on increasing
understanding, and hence, promoting adherence to prescribed medication regimens (Sorfleet,
Vaillancourt, Groves, & Dawson, 2009). A current limitation of its implementation may be tied
to the lack of screening for adherence in practice, signaling the need for stronger evidence.
Conceptual Framework
Concepts from the Health Belief Model (HBM) have been applied to this project
(Rosenstock, 1974). HTN management requires both immediate behavioral change and long-
term behavior maintenance. HBM explains and predicts health behaviors by focusing on the
attitudes and beliefs of individuals (Rosenstock, 1974). The model has six key concepts:
perceived susceptibility (patient's risk and awareness of disease), perceived severity (concept that
a disease can cause morbidity or mortality), perceived benefits (benefit of taking medications),
perceived barriers (obstacles in taking medication like cost, side effects, frequency), cues for
action (factors that can push an individual to take action) and self-efficacy (Rosenstock, 1990).
Several risk factors, including age, gender, socioeconomics, and treatment regimens, may
influence these cognitive constructs and, thus, indirectly result in the health-related behaviors of
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 13
patients (Glanz, Rimer, & Viswanath, 2008). The six constructs of the model were useful when
framing this project intervention to improve medication adherence among HTN patients.
Setting and Organizational Assessment
The setting for the project was an urban, federally-qualified health care clinic that
provides medical care to both insured and uninsured individuals with chronic diseases. The
agency has a licensed primary care adult clinic that provided medical services to 20,402 insured
and uninsured patients in 2017. Of these, 6,010 (29%) had HTN without comorbidities. Half of
these were diagnosed with uncontrolled HTN (Health Resources and Services Administration,
2017; PDCHC Clinical Measures, 2018).
Purpose
The purpose of this quality improvement (QI) project was to implement a sustainable
personalized pictogram pill card intervention for adult outpatients with primary HTN. A long-
term aim for this project was for pictograms to become a standard part of agency primary care
practice.
Intervention
For this QI project, a personalized pictograms pill card was given to 10 patients with
HTN diagnoses who had medium and low adherence scores on the MGL Medication Adherence
Scale. The personalized pictograms pill card conveyed essential information patients should
understand about their medication regimens such as the name, dose, purpose or use, and
frequency and times of administration. Pill cards were created in English at the 6th – 8th -grade
reading level (AHRQ, 2018). Permission to use the web-based tool to create the pill cards for this
QI project was obtained (David I. Lewin, Health Communication Specialist/Manager of
Copyrights & Permissions, personal communication, January 19, 2019).
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 14
Ethics and Human Subjects Protection
Approval for this QI project was obtained from the University of Louisville Institutional
Review Board. A letter of support for the project was obtained from the agency Director of
Nursing (DON). Patients’ personal and health information was protected under the Health
Insurance Portability and Accountability Act (HIPPA) policies. All confidential or protected
patient health information was stored on an encrypted and password-protected laptop. Hard
copies were kept in a secured lock file cabinet in the DON locked office.
Participants
Participants were clinic patients with a single diagnosis of primary HTN who had
medium and low adherence scores on the MGL Medication Adherence Scale. All individuals
were 18 years of age and older, had a provider's diagnosis of HTN without co-morbidity, spoke
English, were on at least one anti-hypertensive medication, self-managed their anti-hypertensive
medication(s), had a working landline or cell phone, and used the clinic pharmacy for
prescription(s).
Data Collection
Patients were assigned a project number to maintain confidentiality, and agency HIPAA
procedures were followed. Completed MGL scales and all identifiable and non-identifiable
project data were stored in a locked file cabinet in the DON locked office. All completed final
analyses were maintained on an encrypted and password-protected project laptop. After
completion of the project, any printed documents were shredded.
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 15
Measures
The MGL Medication Adherence Scale is a validated screening tool designed to assess
medication non-adherence in adults (Morisky, Green, & Levine, 1986). The MGL Medication
Adherence Scale can identify adherence behavior in many chronic disease populations with
scores correlating well with objective adherence measures and clinical outcomes (Morisky et al.,
1986; Wang, Lee, Toh, Tang, & Ko, 2012). Acceptable reliability with a Cronbach's alpha of
>0.70 has been reported (Beyhaghi, Reeve, Rodgers, & Stearns, 2016) with this scale. The MGL
Adherence Scale has several advantages: it is short, easy to score, and very adaptable for various
groups of medication. Items on the scale address barriers to medication taking and permit the
reinforcement of positive adherence behaviors. The total score is based on patient responses to
four "yes" or "no" questions. High adherence is measured by not answering "yes" to any of the
four questions, medium adherence is measured by answering ‘yes" to one or two of the four
questions, and low adherence is measured by answering ‘yes" to three or four of the four
questions. The scale allows for the correct screening for those in which time should be spent on
improving medication adherence. Permission to use the scale for this QI project was obtained
(Donald E. Morisky, personal communication, November 3, 2018).
Procedure
Patients with primary HTN were initially assessed with the MGL Medication Adherence
Scale. Those identified as having medium or low adherence were included in the project.
Immediately following the provider visit, the project leader administered the MGL Medication
Adherence Scale to a patient and scored it. If criteria were met for medium or low adherence, a
personalized medication pill card was created of current antihypertensive medication(s). The
project leader used scripted education material to educate a patient on HTN, non-adherence and
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 16
the use of the personalized pictogram medication pill card. A patient was informed of follow up
phone calls for pill count on day one and 30.
Results
Data were collected and analyzed using the most recent edition of Microsoft Excel.
Demographic data included age, gender, and race/ethnicity. The primary outcome measure for
medication adherence was pill count. The reported pill count was compared to the patients’
expected pill count to calculate the adherence percentage. Adherence was calculated using the
equation recommended by Vik, Maxwell, and Hogan (2003):
% of adherence =# of Pills taken
# of pills that should have been taken X 100
Sixteen patients with primary HTN were initially identified for the project; ten
participated in this project. Six patients did not participate because they initially perceived the
pill card development would take too long. Participants were both male (n=6) and female (n=4)
and had a mean age of 44.5 ± 13.90. The majority (nine) were African American; one patient
was Hispanic.
The mean pre-MGL score was 2.64 ± 2.58 (Table 1). All participants were identified as
having low or medium risk for non-adherence based on the MGL Scale assessment (Table 2).
Seventy percent of patients indicated that they sometimes forget to take their antihypertensive
medication; eighty percent of patients indicated that they were careless at times with taking their
medication(s); thirty percent of the patient indicated that when they felt better, they stopped
taking their medication(s); ten percent indicated that when they felt worse when they took their
medication(s), they stop taking it. Medium adherence was the most common result of the MGL
Scale assessment.
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 17
On day 30 a post MGL scale was conducted to compare mean scores. Post MGL score
mean was 0.1 ± 0.32 (Table 1). All but one participant had high adherence on the post MGL
Scale (Table 2).
All participant rated the pill card as easy to use and a helpful reminder tool for adherence.
One of the participants who completed the intervention provided feedback that “including
pre/post B/P readings” would have been beneficial to the program. The participant who had
medium adherence after completion of the intervention reported her work schedule interfered
with her ability to take her medication on the two days, she forgot to take it.
Table 1:
Pre- and Post-Intervention Mean MGL Scores
Pre
Post
2.64 ± 2.58 0.1 ± 0.32
Table 2:
Pre- and Post-Intervention MGL Medication Adherence Scale Findings
Pre
Post
Low Adherence
Medium Adherence
2
8
0
1
Discussion
Summary Review and Key Findings
The purpose of this project was to implement a pill card intervention to be used for adults
diagnosed with HTN who received care in one primary care setting. The overarching goal of the
project was to develop a standard process of care in the primary care practice setting that
improved medication adherence among hypertensive patients. The project implementation
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 18
process involved adherence screening, educating patients on HTN and non-adherence, and
initiation of the personalized pill card intervention.
Clinical Implication
The pill card intervention improved medication adherence in nine out of the 10 HTN
patients who initially reported low to medium adherence. Data from this project revealed a
similar pattern to that reported in the literature (Kripalani et al., 2007, Monroe et al., 2018).
Findings of this project in that 90% of patients showed improved medication adherence after
participating in the pill card intervention. Mean adherence score was 99.33 ± 2.12. Screening and
education methods specifically designed for patients at risk for medication adherence becomes
essential in addressing this need.
Feasibility
Agency providers and staff were motivated and willing to participate in the project to
improve the medication adherence of identified clinic patients. The time required to administer
the MGL scale, deliver the pill cards and short teaching lessons, and collect pill counts was quite
feasible in this clinic setting. The pill cards were well accepted by the patients in the project.
Overall, the project was simple to implement and provided easily obtainable outcomes to
demonstrate pill count accuracy. Patient education with pill cards fit well in the flow of patient
visits. The development of the cards required little cost, and because the majority of agency
patients have prescriptions filled on-site, pill picture accuracy was assured.
Sustainability and Recommendations
This project provided valuable information regarding the development and
implementation of a pill card intervention in the primary care setting. Pre-intervention
assessment with the MGL scale revealed that many patients have problems with medication
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 19
adherence. These findings also supported the need for healthcare provider interventions that
appropriately identify and address risk factors for poor medication adherence. The pill card
intervention developed and implemented through this project is recommended to continue as a
standard of practice in the primary care setting. The DON of the project clinic is considering
permanent implementation of pill cards. One of the clinic doctors has already started screening
her patients with the MGL Medication Adherence Scale. Equipping healthcare providers and
staff to assess and treat medication non-adherence is an appropriate method of improving patient
medication adherence and thus promoting improved health outcomes.
Limitations
The most notable limitation was the low number of patients in the project. The inclusion
criteria of only using patients with HTN diagnosis and not including all patient medications
limited participation but was necessary to pilot this intervention. Only patients with primary
HTN were included due to concern that patients with multiple prescriptions would
misunderstand the use of their pill cards and discard other prescribed medications for which there
was no pill card.
Conclusion
Poor adherence to antihypertensive medication is a significant risk factor for CVD and
stroke (CDC, 2018). HTN requires both immediate behavioral change and long-term behavior
maintenance to manage the disease and prevent complications. Primary care settings are
appropriate sites to implement proactive strategies such as the screening, education, and
adherence tools used in this project. Educating patients with pill cards as the standard of practice
could improve HTN control, decrease the complications, and reduce overall healthcare costs.
Although this QI project yielded small-scale results due to the small sample size of the project
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 20
and short intervention period, the feasibility of the pictogram pill card-based education in the
outpatient setting and the value of this education for patients were demonstrated.
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 21
References
Agency for Healthcare Research and Quality. (2018). How to create a pill card? Retrieved from
http://www.ahrq.gov/patients-consumers/diagnosis-
treatment/treatments/pillcard/index.html.
Advani, A. A., Lopez, J., Jones, J., & Patel. S. (2013). The role of pictograms for enhancement
of patient prescription medication information in the US. Journal of Pharmacy
Technology, 29(1), 40-50. doi: https://doi.org/10.1177/875512251302900107.
American Heart Association (AHA). (2013). Heart disease and stroke statistics—2013 update: a
report from the American Heart Association. Circulation, 127(1), e6–e245. doi:
10.1161/CIR.0b013e31828124ad.
American College of Preventative Medicine. (2011). Medication adherence-Improving health
outcomes: A resource from the American College of Preventative Medicine. Retrieved
from http://www.acpm.org/?MedAdherTT_ClinRef.
Beyhaghi, H., Reeve, B. B., Rodgers, J. E., & Stearns, S. C. (2016). Psychometric Properties of
the Four-Item Morisky Green Levine Medication Adherence Scale among
Atherosclerosis Risk in Communities (ARIC) Study Participants. Journal of the
International Society of Pharmacoeconomic and Outcome Research, 19(8), 996-1001.
doi: https://doi.org/10.1016/j.jval.2016.07.001.
Braich, P. S., Almeida, D. R., Hollands, S., & Coleman, M. T. (2011). Effects of pictograms in
educating 3 distinct low-literacy populations on the use of postoperative cataract
medication. Canadian Journal of Ophthalmology, 46(3), 276-281.
doi:10.1016/j.jcjo.2011.05.004.
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 22
Centers for Disease Control and Prevention (2014). Blood pressure: make control your goal
infographic. Retrieved from https://www.cdc.gov/bloodpressure/infographic.htm.
Centers for Disease Control and Prevention. (2016). High blood pressure fact sheet. Retrieved
from https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_bloodpressure.htm.
Centers for Disease Control and Prevention (2018). High blood pressure. Retrieved from
https://www.cdc.gov/bloodpressure/index.htm.
Chang, T. E., Ritchey, M. D., Ayala, C., Durthaler, J. M., & Loustalot, F. (2018). Use of
strategies to improve antihypertensive medication adherence within United States
outpatient health care practices, DocStyles 2015-2016. Journal of Clinical Hypertension,
20(1), 225–232. doi: 10.1111/jch.13188.
Dowse, R., & Ehlers, M. (2005). Medicine labels incorporating pictograms: Do they influence
understanding and adherence? Patient Education and Counseling, 58(1), 63-70.
doi:10.1016/j.pec.2004.06.012.
Fryar, C. D., Ostchega, Y., Hales, C.M., Zhang, G., & Kruszon-Moran, D. (2017). Hypertension
prevalence and control among adults: United States, 2015–2016. NCHS data brief, no
289. Hyattsville, MD: National Center for Health Statistics. 2017.
Glanz, K., Rimer, B. K, & Viswanath, K. (2008). Health behavior and health education: theory,
research, and practice. San Francisco, CA: Jossey-Bass.
HealthPeople.gov. (2019). Heart disease and stroke Retrieved from
https://www.healthypeople.gov/2020/topics-objectives/topic/heart-disease-and-stroke.
Health Resources and Services Administration. (2017). 2017 Park DuValle Community Health
Center, Inc. Health Center Profile. Retrieved from
https://bphc.hrsa.gov/uds/datacenter.aspx?q=d&bid=040650&state=KY&year=2017.
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 23
Hamilton, G. A. (2003). Measuring adherence in a hypertension clinical trial. European Journal
of Cardiovascular Nursing, 2(3), 219–228. doi: https://doi.org/10.1016/S1474-
5151(03)00058-6.
Kripalani, S., Robertson, R., Love-Ghaffari, M. H., Henderson, L., Praska, J., Strawder, A.,…
Jacobson, T. A. (2007). Development of an illustrated medication schedule as a low-
literacy patient education tool. Patient Education and Counseling, 66(3), 368–377. doi:
10.1016/j.pec.2007.01.020.
Leporini C, De Sarro G, & Russo E. (2014). Adherence to therapy and adverse drug reactions: Is
there a link? Expert Opinion on Drug Safety, 13(1), S41e55. doi:
10.1517/14740338.2014.947260.
Monroe, A.K., Pena, J. S., Moore, R. D., Riekert, K. A., Eakin, M. N., Kripalani, S., & Chander,
G. (2018). Randomized controlled trial of a pictorial aid intervention for medication
adherence among HIV-positive patients with comorbid diabetes or hypertension. AIDS
Care, 30(2). https://doi.org/10.1080/09540121.2017.1360993.
Mansoor, L. E., & Dowse, R. (2006). Medicines information and adherence in HIV/AIDS
patients. Journal of Clinical Pharmacology Therapeutics, 31(1):7–15. doi:
10.1111/j.1365-2710.2006.00696.x.
Mansoor, L. E., & Dowse, R. (2003). Effect of pictograms on readability of patient information
materials. Annals of Pharmacotherapy, 37(7-8), 1003-1009. doi:10.1345/aph.1C449.
Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a
self-reported measure of medication adherence. Medical Care, 24(1), 67–74.
Park DuValle Community Health Center. (2018). Park DuValle Community Health Center
Clinical Quality Measures.
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 24
Rosenstock, I. M. (1990). The Health Belief Model: Explaining health behavior through
expectancies. In K. Glanz, F. M. Lewis, & B. K. Rimer (Eds.), Health behavior and
health education: Theory, research and practice (pp. 39–62). San Francisco: Jossey-Bass.
Rosenstock, I. M. (1974). The health belief model and preventive health behavior. Health
Education Monographs, 2(4), 354–436. doi:
https://doi.org/10.1177/109019817400200405.
Sorfleet, C., Vaillancourt, R., Groves, S., & Dawson, J. (2009). Design, development, and
evaluation of pictographic instructions for medications used during humanitarian
missions. Canadian Pharmacists Journal, 142(2), 82–88. doi: 10.3821/1913-701X-
142.2.82.
United States Department of Health and Human Services (DHHS). (2016). Cardiovascular health
medication adherence: action steps for public health practitioners. Atlanta, GA. Retrieved
from https://millionhearts.hhs.gov/files/Medication-Adherence- Action-Guide-for-
PHPs.pdf.
Vik, S. A., Maxwell, C. J., & Hogan, D. B. (2004). Measurement, correlates, and health
outcomes of medication adherence among seniors. Annals of Pharmacotherapy, 38(2),
303–312. doi: 10.1345/aph.1d252.
Wang, Y., Lee, J., Toh. M. P., Tang, W. E., & Ko, Y. (2012). Validity and reliability of a self-
reported measure of medication adherence in patients with type 2 diabetes mellitus in
Singapore. Diabetes Medicine, 29(9), e338-44. doi: 10.1111/j.1464-5491.2012.03733.x.
Wilby, K., Marra, C. A., da Silva, J. H Grubisic, M., Harvard, S., & Lynd, L. D. (2011).
Randomized controlled trial evaluating pictogram augmentation of HIV medication
information. The Annals of Pharmacotherapy, 45(11), 1378-83. doi: 10.1345/aph.1Q091.
IMPROVING ADHERENCE IN ADULTS WITH HYPERTENSION 25
Wogen, J., & French, F. (2004). Patient adherence with hypertension medication. Journal of
Managed Care Pharmacy, 10, 90–101. Retrieved from
http://scholar.google.com/scholar_url?url=https%3A%2F%2Fwww.jmcp.org%2Fdoi%2F
pdf%2F10.18553%2Fjmcp.2004.10.1.90&hl=en&sa=T&oi=gga&ct=gga&cd=0&d=8463
644413458947183&ei=BgX8XNyMN8uLyQSmg4OYCA&scisig=AAGBfm021f20Yx5i
NHOMnarGQ18SjGH8lQ&nossl=1&ws=1920x1082&at=Patient%20adherence%20with
%20hypertension%20medication&bn=1.
Yoon, S. S., Fryar, C., & Carrol, M. (2015). Hypertension prevalence and control among adults:
United States, 2011–2014. National Center for Health Statistics data brief, (220):1–8.
Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26633197.